Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) was the recipient of a significant increase in short interest during the month of May. As of May 29th, there was short interest totaling 11,366 shares, an increase of ? from the May 14th total of 0 shares. Based on an average daily trading volume, of 40,703 shares, the days-to-cover ratio is currently 0.3 days.
Fortress Biotech Price Performance
Shares of Fortress Biotech stock opened at $20.88 on Tuesday. Fortress Biotech has a fifty-two week low of $6.27 and a fifty-two week high of $21.43. The business has a 50-day moving average price of $15.98 and a 200 day moving average price of $12.94.
About Fortress Biotech
Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.
The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.
Featured Stories
- Five stocks we like better than Fortress Biotech
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
